The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response
Primary Purpose
Body Weight, Oxidative Stress, Trimethylamine N-oxide
Status
Completed
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Meatless, restrictive ketogenic diet
Sponsored by
About this trial
This is an interventional basic science trial for Body Weight focused on measuring ketogenic diet, ketosis, oxidative stress, immune response, insulin resistance, body composition, strength capacity, omega 3 acids, meatless diet
Eligibility Criteria
Inclusion Criteria:
- male or female
- healthy
- age 32 - 59
- non-smoker
- not abusing alcohol
- not subjected to physical exercise for at least 48 hours before the examination
Exclusion Criteria:
- cardiovascular,
- thyroid disease,
- gastrointestinal,
- respiratory
- or any other metabolic diseases adherence to special diets, use of nutritional supplements and use of medication to control blood lipids or glucose
Sites / Locations
- Poznan University of Physical Education
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Meatless restrictive ketogenic diet
Arm Description
Diet was designed to be isoproteic (1.8 g x Kg- 1 x body weight- 1 x day-1) with three meals a day., restrictive (EER minus 500 kcal / day). The distribution of macronutrients during the very low carbohydrate ketogenic diet (KD) was: protein 1.8 g x Kg-1 x body weight- 1 x day-1 (~ 25-30%), fats (~ 65-70%, with a strong emphasis on the content of omega 3 fatty acids) and carbohydrate (< 30 g x day- 1; < 10%).
Outcomes
Primary Outcome Measures
Body composition
Whole body and regional body composition were measured in the morning after a 12 hours overnight fast by dual energy X-ray absorptiometry (DEXA) Body Composition: Body Fat Mass, Fat Free Mass, and Visceral Body Fat
Body Fat Mass [Kg] max 40.143 Kg min 11.129 Kg (higher scores mean a worse outcome)
Fat Free Mass [Kg] max 68.527 Kg min 37.72 Kg (higher scores mean a better outcome)
Visceral Body Fat [g] max 2139 g min 90 g (higher scores mean a worse outcome)
Body weight
Body weight was measured with an accuracy of 0.1 Kg using an electronic scale (Tanita BC-601, Japan)
Body weight (higher scores mean a worse outcome) [Kg] max 95.7 Kg min 60.9 Kg
TMAO
Trimethylamine N-Oxide (measured by Institute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw Poland)
TMAO [ng/ml] (higher scores mean a worse outcome)
Lipids level (TC, HDL, LDL, TG)
Level of lipids - (TC- Total Cholesterol, LDL- low-density lipoprotein, HDL- high-density lipoprotein, TG - triacylglycerol)
TC [mg/dl] (higher scores mean a worse outcome) LDL [mg/dl] (higher scores mean a worse outcome) TG [mg/dl] (higher scores mean a worse outcome) HDL [mg/dl] (higher scores mean a better outcome)
glucose level (blood, urine)
glucose level (blood, urine) - measured by Ketodiastix and Optimum Xido Neo
higher scores mean a worse outcome
ketone bodies (blood, urine)
ketone bodies (blood, urine) - measured by Ketodiastix and Optimum Xido Neo
higher scores mean a better outcome
inflammatory markers
inflammatory markers (including IFN-y, IL-6, IL-8, IL-10, TNF-a, IL-2, IL-4) - Luminex method with the use of BioRad BioPlex 200 reader Pro and anti-inflammatory cytokines (Bio-Plex Pro ™ Human Cytokine 8-plex Assay M50000007A, BIO-RAD, USA)
depends - higher scores mean a better or worse outcome
markers of oxidative stress 1
markers of oxidative stress - concentration of protein carbonyl groups - Colorimetric method; Plate-based colorimetric measurement (360-385 nm) (concentration of protein carbonyl groups: Protein Carbonyl Colorimetric Assay Kit No. 100005020 (Cayman Chemical, Ann Arbor, MI, USA)
higher scores mean a worse outcome
markers of oxidative stress 2
markers of oxidative stress - concentration of protein thiol group
higher scores mean a worse outcome
metabolic panel - diabetes
metabolic panel - diabetes (including ghrelin, glucagon, insulin, leptin, resistin) - Luminex method with the use of BioRad BioPlex 200 readerm (Bio-Plex Pro ™ Human Diabetes 10-Plex Assay # M171A7001M, BIO-RAD, USA)
depends - higher scores mean a better or worse outcome
somatic disorders
Somatic disorders measured by questionnaire based on Likert's scale
Likert's scale:
- Strongly disagree
- Disagree
- Neither agree nor disagree
- Agree
- Strongly agree
It depends on question - higher scores mean a better or worse outcome
Secondary Outcome Measures
Full Information
NCT ID
NCT05558488
First Posted
September 23, 2022
Last Updated
September 28, 2022
Sponsor
Katarzyna Siedzik
1. Study Identification
Unique Protocol Identification Number
NCT05558488
Brief Title
The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response
Official Title
Effect of a Meatless,Ketogenic Restrictive Diet on Body Composition, Concentration of Trimethylamine N-Oxide (TMAO),Ketone Bodies and Glucose in Blood and Urine, Somatic Disorders, Strength Capacity, Oxidative Stress, Immune Response
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2019 (Actual)
Primary Completion Date
June 30, 2021 (Actual)
Study Completion Date
August 31, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Katarzyna Siedzik
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The subject of doctoral dissertation: Assessment of the effects of a meatless, ketogenic restrictive diet on body composition, strength capacity, oxidative stress and immune response
During planning of research and topic of the doctoral dissertation, it was considered how to modify a standard ketogenic diet rich in saturated fatty acids so that the use of this model of nutrition has the most anti-inflammatory effect. Therefore, it was decided to conduct a research to check whether a diet rich in omega-3 polyunsaturated fatty acids will show such an effect when following a high-fat diet.
Hypotheses:
1. The ketogenic diet reduces systemic inflammation. 2.The ketogenic diet reduces oxidative stress. 3. The ketogenic diet reduces body fat. 4. A ketogenic diet does not worsen strength performance.
Detailed Description
a) main research assumption
Reports in the international literature regarding the importance of the ketogenic diet are ambiguous. Some researchers believe that its use reduces body fat and improves insulin sensitivity or lipid profile, while others question this view and question it. Many authors emphasized the need for further research in this area, and this outline of the research project responds to this postulate.
In the presented experiment, the duration of a single experiment was 14 days, because the individual adaptation period of each participant should be taken into account - the so-called "keto-adaptation".
In order to assess the effectiveness of the nutritional intervention in this experiment, the following were performed: blood sampling for the determination of basic parameters (lipid profile, fasting glucose, fasting insulin, diabetic panel, hormones), determination of glucose and ketone bodies (β ketones) in the blood using a strip test - Optium Xido Neo glucometer, determination of the concentration of ketone bodies (acetoacetic acid) and glucose in the urine using Keto-Diastix - a strip test, examination by means of tests - force (maximum isokinetic force test with the use of Biodex apparatus), determination of inflammatory markers (TNF alpha, pro-inflammatory, anti-inflammatory and pro-or anti-inflammatory interleukins depending on the conditions), determination of oxidative stress markers - related to free radical damage to proteins (carbonyl groups, sulfhydryl groups (SH groups)), body composition measurement using the DEXA method (Dual Energy X-ray Absorptiometry). Choosing this method instead of the very common bioimpedance, due to the fact that using densitometry, it obtained very precise results of adipose tissue.
The above-described procedures were used to check the molecular basis of the phenomenon under study, to determine the parameters in which significant changes are visible and to determine the extent to which they translate into the function of the muscle and the subjective feelings of the subject.
Research methodology:
body composition (DEXA)- Isometric muscle strength (Biodex)
blood tests (lipid profile, glucose, insulin, ketone bodies)
inflammatory markers - Luminex method with the use of BioRad BioPlex 200 reader Pro and anti-inflammatory cytokines (Bio-Plex Pro ™ Human Cytokine 8-plex Assay M50000007A, BIO-RAD, USA) (including IFN-y, IL-6, IL-8, IL-10, TNF-a, IL-2, IL-4)
metabolic panel - Luminex method with the use of BioRad BioPlex 200 readerm (Bio-Plex Pro ™ Human Diabetes 10-Plex Assay # M171A7001M, BIO-RAD, USA) (including ghrelin, glucagon, insulin, leptin, resistin)
markers of oxidative stress - Colorimetric method; Plate-based colorimetric measurement (360-385 nm) (concentration of protein carbonyl groups: Protein Carbonyl Colorimetric Assay Kit No. 100005020 (Cayman Chemical, Ann Arbor, MI, USA)
markers of oxidative stress (concentration of protein thiol groups)
TMAO (trimethylamine N-oxide)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Body Weight, Oxidative Stress, Trimethylamine N-oxide, Immunologic Factors, Glucose Metabolism Disorders, Insulin Resistance, Insulin Sensitivity, Insulin Tolerance, Carbohydrate Metabolism Disorder, Lipid Metabolism Disorders, Body Fat Disorder, Ketosis, Ketoses, Metabolic, Somatic Disorders
Keywords
ketogenic diet, ketosis, oxidative stress, immune response, insulin resistance, body composition, strength capacity, omega 3 acids, meatless diet
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Each participant received a nutritional plan that was the same qualitatively but differed quantitatively. It was calculated for each individual based on the Mifflin-St Jeor Equation (Basal Metabolic Rate).
After that, the levels of physical activity (PAL) were used to assess physical activity patterns and energy expenditure of individuals for placement into one of four PAL categories: sedentary, low active, active, or very active. That helped to calculate EER and made an individual reduction (minus 500 kcal / day). Before the start of the study, each participant obtained information about the basic principles of the ketogenic diet. Diet was designed to be isoproteic (1.8 g x Kg- 1 x body weight- 1 x day-1) with three meals a day. The distribution of macronutrients during the ketogenic diet (KD) was: protein 1.8 g x Kg-1 x body weight- 1 x day-1 (~ 25-30%), fats (~ 65-70%, with a strong emphasis on the content of omega 3 fatty acids) and carbohydrate (< 30 g x day- 1; < 10%).
Masking
None (Open Label)
Allocation
N/A
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Meatless restrictive ketogenic diet
Arm Type
Experimental
Arm Description
Diet was designed to be isoproteic (1.8 g x Kg- 1 x body weight- 1 x day-1) with three meals a day., restrictive (EER minus 500 kcal / day). The distribution of macronutrients during the very low carbohydrate ketogenic diet (KD) was: protein 1.8 g x Kg-1 x body weight- 1 x day-1 (~ 25-30%), fats (~ 65-70%, with a strong emphasis on the content of omega 3 fatty acids) and carbohydrate (< 30 g x day- 1; < 10%).
Intervention Type
Other
Intervention Name(s)
Meatless, restrictive ketogenic diet
Intervention Description
Each participant received a nutritional plan that was the same qualitatively but differed quantitatively - a 500 kcal reduction based on Estimated Energy Requirement (EER) was assumed. Before the start of the study, each participant obtained information about the basic principles of the ketogenic diet. Diet was designed to be isoproteic (1.8gxKg-1xbody weight-1xday-1) with three meals a day. The distribution of macronutrients during the very low carbohydrate ketogenic diet (KD) was: protein 1.8 gxKg-1xbody weight-1xday-1(~25-30%), fats (~65-70%,with a strong emphasis on the content of omega 3 fatty acids) and carbohydrate (<30gxday-1;<10%).
The food lists encouraged the consumption of fish,raw and cooked vegetables, eggs,fruits with the lowest glycemic index (blueberry, raspberry), plant oils and fats from avocado,olives.Drinks permitted were tea, coffee without sugar and the foods and drinks to be avoided were alcohol,meat (any kind of meat),bread,pasta,rice,milk,dairy and potatoes.
Primary Outcome Measure Information:
Title
Body composition
Description
Whole body and regional body composition were measured in the morning after a 12 hours overnight fast by dual energy X-ray absorptiometry (DEXA) Body Composition: Body Fat Mass, Fat Free Mass, and Visceral Body Fat
Body Fat Mass [Kg] max 40.143 Kg min 11.129 Kg (higher scores mean a worse outcome)
Fat Free Mass [Kg] max 68.527 Kg min 37.72 Kg (higher scores mean a better outcome)
Visceral Body Fat [g] max 2139 g min 90 g (higher scores mean a worse outcome)
Time Frame
2 weeks
Title
Body weight
Description
Body weight was measured with an accuracy of 0.1 Kg using an electronic scale (Tanita BC-601, Japan)
Body weight (higher scores mean a worse outcome) [Kg] max 95.7 Kg min 60.9 Kg
Time Frame
2 weeks
Title
TMAO
Description
Trimethylamine N-Oxide (measured by Institute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw Poland)
TMAO [ng/ml] (higher scores mean a worse outcome)
Time Frame
2 weeks
Title
Lipids level (TC, HDL, LDL, TG)
Description
Level of lipids - (TC- Total Cholesterol, LDL- low-density lipoprotein, HDL- high-density lipoprotein, TG - triacylglycerol)
TC [mg/dl] (higher scores mean a worse outcome) LDL [mg/dl] (higher scores mean a worse outcome) TG [mg/dl] (higher scores mean a worse outcome) HDL [mg/dl] (higher scores mean a better outcome)
Time Frame
2 weeks
Title
glucose level (blood, urine)
Description
glucose level (blood, urine) - measured by Ketodiastix and Optimum Xido Neo
higher scores mean a worse outcome
Time Frame
2 weeks
Title
ketone bodies (blood, urine)
Description
ketone bodies (blood, urine) - measured by Ketodiastix and Optimum Xido Neo
higher scores mean a better outcome
Time Frame
2 weeks
Title
inflammatory markers
Description
inflammatory markers (including IFN-y, IL-6, IL-8, IL-10, TNF-a, IL-2, IL-4) - Luminex method with the use of BioRad BioPlex 200 reader Pro and anti-inflammatory cytokines (Bio-Plex Pro ™ Human Cytokine 8-plex Assay M50000007A, BIO-RAD, USA)
depends - higher scores mean a better or worse outcome
Time Frame
2 weeks
Title
markers of oxidative stress 1
Description
markers of oxidative stress - concentration of protein carbonyl groups - Colorimetric method; Plate-based colorimetric measurement (360-385 nm) (concentration of protein carbonyl groups: Protein Carbonyl Colorimetric Assay Kit No. 100005020 (Cayman Chemical, Ann Arbor, MI, USA)
higher scores mean a worse outcome
Time Frame
2 weeks
Title
markers of oxidative stress 2
Description
markers of oxidative stress - concentration of protein thiol group
higher scores mean a worse outcome
Time Frame
2 weeks
Title
metabolic panel - diabetes
Description
metabolic panel - diabetes (including ghrelin, glucagon, insulin, leptin, resistin) - Luminex method with the use of BioRad BioPlex 200 readerm (Bio-Plex Pro ™ Human Diabetes 10-Plex Assay # M171A7001M, BIO-RAD, USA)
depends - higher scores mean a better or worse outcome
Time Frame
2 weeks
Title
somatic disorders
Description
Somatic disorders measured by questionnaire based on Likert's scale
Likert's scale:
- Strongly disagree
- Disagree
- Neither agree nor disagree
- Agree
- Strongly agree
It depends on question - higher scores mean a better or worse outcome
Time Frame
2 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
32 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
male or female
healthy
age 32 - 59
non-smoker
not abusing alcohol
not subjected to physical exercise for at least 48 hours before the examination
Exclusion Criteria:
cardiovascular,
thyroid disease,
gastrointestinal,
respiratory
or any other metabolic diseases adherence to special diets, use of nutritional supplements and use of medication to control blood lipids or glucose
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katarzyna Siedzik, MSc
Organizational Affiliation
Poznan University of Physical Education, Poznan, Poland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Poznan University of Physical Education
City
Poznań
State/Province
Wielkopolskie
ZIP/Postal Code
61-871
Country
Poland
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
15507148
Citation
Phinney SD. Ketogenic diets and physical performance. Nutr Metab (Lond). 2004 Aug 17;1(1):2. doi: 10.1186/1743-7075-1-2.
Results Reference
background
PubMed Identifier
22327146
Citation
Paoli A, Grimaldi K, Toniolo L, Canato M, Bianco A, Fratter A. Nutrition and acne: therapeutic potential of ketogenic diets. Skin Pharmacol Physiol. 2012;25(3):111-7. doi: 10.1159/000336404. Epub 2012 Feb 11.
Results Reference
background
PubMed Identifier
23801097
Citation
Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013 Aug;67(8):789-96. doi: 10.1038/ejcn.2013.116. Epub 2013 Jun 26. Erratum In: Eur J Clin Nutr. 2014 May;68(5):641.
Results Reference
background
PubMed Identifier
25698989
Citation
Paoli A, Bosco G, Camporesi EM, Mangar D. Ketosis, ketogenic diet and food intake control: a complex relationship. Front Psychol. 2015 Feb 2;6:27. doi: 10.3389/fpsyg.2015.00027. eCollection 2015.
Results Reference
background
PubMed Identifier
19641727
Citation
Dashti HM, Mathew TC, Hussein T, Asfar SK, Behbahani A, Khoursheed MA, Al-Sayer HM, Bo-Abbas YY, Al-Zaid NS. Long-term effects of a ketogenic diet in obese patients. Exp Clin Cardiol. 2004 Fall;9(3):200-5.
Results Reference
background
PubMed Identifier
14769489
Citation
Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):309-19. doi: 10.1016/j.plefa.2003.09.007.
Results Reference
background
PubMed Identifier
2656155
Citation
Balasse EO, Fery F. Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev. 1989 May;5(3):247-70. doi: 10.1002/dmr.5610050304.
Results Reference
background
Learn more about this trial
The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response
We'll reach out to this number within 24 hrs